Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 162 (RN7SKP162) is annotated as a pseudogene in the human genome and does not encode a functional RNA or protein product. It is related to the 7SK small nuclear RNA gene, a critical non-coding RNA involved in regulating transcription elongation by sequestration of the positive transcription elongation factor b (P-TEFb)[1][3]. As a pseudogene, RN7SKP162 is presumed to be nonfunctional, is not considered a drug target or biologically active molecule, and is not known to have a role in disease, as a biomarker, or as a therapeutic target[1][3][7]. It should not be confused with the functional 7SK RNA gene (RN7SK), which is biologically significant[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 162 (RN7SKP162).